Here are relevant reports on : live-visuals-market
-
Military Simulation and Training Market by Application (Army, Aviation, Naval), Type (Live, Virtual, Constructive), Platform (Land, Maritime, Airborne), Solution, Environment (Synthetic, Gaming), Technology, and Region - Global Forecast
The Military Simulation and Training market size is projected to reach USD 12.2 billion by 2027, at a CAGR of 5.6% during the forecast period. This region is expected to lead the market from 2021 to 2026, owing to increased investments and the adoption of advanced military simulators for all the platforms by countries in this region. The presence of prominent manufacturers and integrators of these Military Simulation and Training, including Lockheed Martin (US), Northrop Grumman (US), L3Harris Technologies, Inc. (US), and Raytheon Technologies (US), is also expected drive the market in the region over the forecast period.
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Poultry Processing Equipment Market by Equipment Type (Live Bird Handling, Slaughtering & Defeathering, Evisceration, Cut-up & Portioning, Deboning & Filleting, Others), Product Type, Automation Level, Plant Capacity, and Region - Global Forecast to 2035
The poultry processing equipment market is estimated to be USD 4.97 billion in 2026 and is projected to reach USD 8.61 billion by 2035, registering a CAGR of 6.3% from 2026 to 2035. The key players include JBT Marel Corporation (US), GEA Group Aktiengesellschaft (Germany), BAADER Group (Germany), Meyn Food Processing Technology B.V. (Netherlands), Middleby Corporation (US), Duravant LLC (US), Mayekawa Mfg. Co., Ltd. (Japan), Bayle SA (France), Cattaruzzi Srl (Italy), Drobtech (Poland), Cantrell Gainco Group, Inc. (US), Jilin SSK Electromechanical Co., Ltd. (China), Dutch Poultry Technology B.V. (Netherlands), Meitech (Brazil), and Wrightfield Ltd. (UK), among others.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Bovine, Ruminant, Canine, Feline, Aquaculture), Technology (Live Attenuated, Inactivated, Toxoid, Recombinant), Route of Administration (Subcutaneous, Oral), End User - Global Forecast to 2031
The global veterinary vaccines market is projected to reach USD 18.46 billion by 2031, growing at a CAGR of 7.2% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Military vaccination Market (Live attenuated Vaccine, Inactivated/Killed vaccine, Toxoid vaccine & Subunit/conjugate vaccine), Immunization ( active & passive), Troop health protection (First Aid & Surgical Instruments) & By Geography - Forecast & Analysis(2014-2020)
In armed forces across the globe, the armed personals are given vaccine and are immunized from the external viruses in order to continuously improve the readiness of the army men and women for any kind of emergency situations. It is very important to keep the armed personals healthy as they play a crucial role in safeguarding the people of the nations. To provide the healthy and protected environment for the defense personals and their families, the vaccines and the immunizing agents are provided to the armed personals at proper schedule or during the case of emergencies.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Value Added Services (VAS) Market (Content Provider , Customer Delight, Online Gaming, Utility Services, Live Streaming, SMS, MMS, Mobile Money & M-commerce based services, M-health) - Advancements, Forecasts & Analysis (2014 - 2019)
Value added services (VAS) market in the emerging nations have immense potential. Affordable mobile devices and cheaper data subscription rates are expected to push the mobile value added services market further.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031
The global human microbiome market, valued at USD 0.91 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 31.0% from 2025 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period. North American market held the largest share during the forecast period due to the rising investments by governments and industries, and presence of a strong human microbiome ecosystem supporting innovation in this field.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at USD3.84 billion in 2025, stood at USD4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of USD5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The Asia Pacific Vaccines market, valued at USD 9.46 billion in 2024, stood at USD 9.89 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of USD14.57 billion by the end of the period. The market is expanding quickly, driven by a rise in vaccine development and commercialization, heightened infectious disease rates, and the extensive use of preventive vaccines.
- Published: August 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
